Jeremy Nicholas Burrows;Ulrika Yngve;Erica Tjerneld;Per I. Arvidsson
发明人:
Jeremy Nicholas Burrows,Per I. Arvidsson,Erica Tjerneld,Ulrika Yngve
申请号：
US13264529
公开号：
US20120077813A1
申请日:
2010.04.14
申请国别(地区):
US
年份:
2012
代理人:
摘要：
The present invention relates to a new compound of formula (I) wherein R1 is hydrogen or fluoro； R2 and R3 are independently selected from hydrogen or methyl； or a pharmaceutically acceptable salt thereof, pharmaceutical formulations containing said compound, to the use of said active compound in therapy, to the use for the treatment of conditions associated with glycogen synthase kinase-3 related disorders, such as Alzheimer's disease, as well as for the method of treatment of said disorders, comprising administering to a mammal, including human in need of such treatment, a therapeutically effective amount of said compound.
